May 8, 2024 · Velcade injection is a proteasome inhibitor, a type of targeted cancer drug. Velcade injection is not chemotherapy. Velcade works by blocking enzymes (proteasomes), which usually …

Mar 7, 2025 · Velcade® (bortezomib) is an injectable anti-cancer agent used in various stages of multiple myeloma. See potential side effects and other information.

Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. [4] This includes multiple myeloma in those who …

VELCADE (bortezomib) for Injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy. VELCADE (bortezomib) is administered as a 3-5...

Oct 6, 2024 · Overview: Bortezomib (Velcade, Boruzu) is used to treat certain blood cancers, including multiple myeloma and mantle cell lymphoma.

May 9, 2022 · Velcade (bortezomib) is a recommended anticancer treatment option for multiple myeloma and mantle cell lymphoma in adults. It's given as an injection under the skin …

Velcade (bortezomib) is a proteasome inhibitor for patients with multiple myeloma or mantle cell lymphoma. See its full prescribing information.

It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. This medicine may be used for other purposes; ask your health care …

Jul 13, 2025 · Velcade is a prescription drug used to treat certain types of cancer. Learn about its common, mild, and serious side effects and how to manage them.

Dec 20, 2022 · Velcade (Bortezomib) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources.